Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis

OBJECTIVE: Dimethyl fumarate (DMF), a therapy for relapsing‐remitting multiple sclerosis (RRMS), is implicated as acting on inflammatory and antioxidant responses within both systemic immune and/or central nervous system (CNS) compartments. Orally administered DMF is rapidly metabolized to monomethy...

Descripción completa

Detalles Bibliográficos
Autores principales: Michell‐Robinson, Mackenzie A., Moore, Craig S., Healy, Luke M., Osso, Lindsay A., Zorko, Nika, Grouza, Vladimir, Touil, Hanane, Poliquin‐Lasnier, Laurence, Trudelle, Anne‐Marie, Giacomini, Paul S., Bar‐Or, Amit, Antel, Jack P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704479/
https://www.ncbi.nlm.nih.gov/pubmed/26783548
http://dx.doi.org/10.1002/acn3.270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704479/
https://www.ncbi.nlm.nih.gov/pubmed/26783548
http://dx.doi.org/10.1002/acn3.270

Ejemplares similares